Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Cell Mol Med ; 26(9): 2483-2504, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-35426198

RESUMEN

As the number of confirmed cases and resulting death toll of the COVID-19 pandemic continue to increase around the globe - especially with the emergence of new mutations of the SARS-CoV-2 virus in addition to the known alpha, beta, gamma, delta and omicron variants - tremendous efforts continue to be dedicated to the development of interventive therapeutics to mitigate infective symptoms or post-viral sequelae in individuals for which vaccines are not accessible, viable or effective in the prevention of illness. Many of these investigations aim to target the associated acute respiratory distress syndrome, or ARDS, which induces damage to lung epithelia and other physiologic systems and is associated with progression in severe cases. Recently, stem cell-based therapies have demonstrated preliminary efficacy against ARDS based on a number of preclinical and preliminary human safety studies, and based on promising outcomes are now being evaluated in phase II clinical trials for ARDS. A number of candidate stem cell therapies have been found to exhibit low immunogenicity, coupled with inherent tropism to injury sites. In recent studies, these have demonstrated the ability to modulate suppression of pro-inflammatory cytokine signals such as those characterizing COVID-19-associated ARDS. Present translational studies are aiming to optimize the safety, efficacy and delivery to fully validate stem cell-based strategies targeting COVID-19 associated ARDS for viable clinical application.


Asunto(s)
COVID-19 , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas , Síndrome de Dificultad Respiratoria , COVID-19/complicaciones , COVID-19/terapia , Humanos , Trasplante de Células Madre Mesenquimatosas/métodos , Pandemias , Síndrome de Dificultad Respiratoria/etiología , Síndrome de Dificultad Respiratoria/terapia , SARS-CoV-2
2.
Int J Mol Sci ; 21(23)2020 Nov 26.
Artículo en Inglés | MEDLINE | ID: mdl-33256086

RESUMEN

Glioblastoma is a type of aggressive brain tumor that grows very fast and evades surrounding normal brain, lead to treatment failure. Glioblastomas are associated with Akt activation due to somatic alterations in PI3 kinase/Akt pathway and/or PTEN tumor suppressor. Sodium meta-arsenite, KML001 is an orally bioavailable, water-soluble, and trivalent arsenical and it shows antitumoral effects in several solid tumor cells via inhibiting oncogenic signaling, including Akt and MAPK. Here, we evaluated the effect of sodium meta-arsenite, KML001, on the growth of human glioblastoma cell lines with different PTEN expression status and Akt activation, including PTEN-deficient cells (U87-MG and U251) and PTEN-positive cells (LN229). The growth-inhibitory effect of KML001 was stronger in U87-MG and U251 cells, which exhibited higher Akt activity than LN229 cells. KML001 deactivated Akt and decreased its protein levels via proteasomal degradation in U87-MG cells. KML001 upregulated mutant PTEN levels via inhibition of its proteasomal degradation. KML001 inhibited cell growth more effectively in active Akt-overexpressing LN229 cells than in mock-expressing LN229 cells. Consistent with these results, KML001 sensitized PTEN-deficient cells more strongly to growth inhibition than it did PTEN-positive cells in prostate and breast cancer cell lines. Finally, we illustrated in vivo anti-tumor effects of KML001 using an intracranial xenograft mouse model. These results suggest that KML001 could be an effective chemotherapeutic drug for the treatment of glioblastoma cancer patients with higher Akt activity and PTEN loss.


Asunto(s)
Antineoplásicos/uso terapéutico , Arsenitos/uso terapéutico , Neoplasias Encefálicas/tratamiento farmacológico , Neoplasias Encefálicas/enzimología , Glioblastoma/tratamiento farmacológico , Glioblastoma/enzimología , Proteínas Proto-Oncogénicas c-akt/metabolismo , Compuestos de Sodio/uso terapéutico , Animales , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Arsenitos/farmacología , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/patología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Regulación hacia Abajo/efectos de los fármacos , Activación Enzimática/efectos de los fármacos , Femenino , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Glioblastoma/genética , Glioblastoma/patología , Humanos , Ratones Endogámicos BALB C , Ratones Desnudos , Fosfohidrolasa PTEN/metabolismo , Compuestos de Sodio/farmacología , Regulación hacia Arriba/efectos de los fármacos , Ensayos Antitumor por Modelo de Xenoinjerto
3.
J Biol Chem ; 291(7): 3209-23, 2016 Feb 12.
Artículo en Inglés | MEDLINE | ID: mdl-26655716

RESUMEN

The epithelial cells of the gut form a physical barrier against the luminal contents. The collapse of this barrier causes inflammation, and its therapeutic restoration can protect the gut against inflammation. EGF enhances mucosal barrier function and increases colonocyte proliferation, thereby ameliorating inflammatory responses in the gut. Based on our previous finding that the insect peptide CopA3 promotes neuronal growth, we herein tested whether CopA3 could increase the cell proliferation of colonocytes, enhance mucosal barrier function, and ameliorate gut inflammation. Our results revealed that CopA3 significantly increased epithelial cell proliferation in mouse colonic crypts and also enhanced colonic epithelial barrier function. Moreover, CopA3 treatment ameliorated Clostridium difficile toxin As-induced inflammation responses in the mouse small intestine (acute enteritis) and completely blocked inflammatory responses and subsequent lethality in the dextran sulfate sodium-induced mouse model of chronic colitis. The marked CopA3-induced increase of colonocyte proliferation was found to require rapid protein degradation of p21(Cip1/Waf1), and an in vitro ubiquitination assay revealed that CopA3 directly facilitated ubiquitin ligase activity against p21(Cip1/Waf1). Taken together, our findings indicate that the insect peptide CopA3 prevents gut inflammation by increasing epithelial cell proliferation and mucosal barrier function.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Péptidos Catiónicos Antimicrobianos/uso terapéutico , Escarabajos/metabolismo , Colitis/prevención & control , Enteritis/prevención & control , Fármacos Gastrointestinales/uso terapéutico , Proteínas de Insectos/uso terapéutico , Mucosa Intestinal/efectos de los fármacos , Animales , Animales no Consanguíneos , Antiinflamatorios no Esteroideos/farmacología , Péptidos Catiónicos Antimicrobianos/farmacología , Proliferación Celular/efectos de los fármacos , Colitis/inmunología , Colitis/metabolismo , Colitis/patología , Colon/efectos de los fármacos , Colon/inmunología , Colon/metabolismo , Colon/patología , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/antagonistas & inhibidores , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/genética , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/metabolismo , Enteritis/inmunología , Enteritis/metabolismo , Enteritis/patología , Fármacos Gastrointestinales/farmacología , Células HT29 , Humanos , Proteínas de Insectos/farmacología , Mucosa Intestinal/inmunología , Mucosa Intestinal/patología , Intestino Delgado/efectos de los fármacos , Intestino Delgado/inmunología , Intestino Delgado/metabolismo , Intestino Delgado/patología , Masculino , Ratones Endogámicos C57BL , Permeabilidad/efectos de los fármacos , Interferencia de ARN , Técnicas de Cultivo de Tejidos , Ubiquitina-Proteína Ligasas/química , Ubiquitina-Proteína Ligasas/genética , Ubiquitina-Proteína Ligasas/metabolismo , Ubiquitinación/efectos de los fármacos
4.
J Pept Sci ; 23(11): 833-839, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28949065

RESUMEN

Many reports have shown that crude extracts of the American cockroach have therapeutic effects on inflammation. In a previous study, our research group showed that an antimicrobial peptide (Periplanetasin-2) derived from the American cockroach via de novo transcriptome analysis inhibited apoptosis of human colonocytes and inflammatory responses of the mouse gut caused by Clostridium difficile toxin A. Here, we examined whether Periplanetasin-4 (Peri-4), another antimicrobial peptide identified via de novo transcriptome analysis of the American cockroach, could also inhibit the various toxicities induced by C. difficile toxin A. We found that Peri-4 significantly reduced the cell viability loss and cell apoptosis caused by toxin A in vitro. Peri-4 also ameliorated the severe inflammatory responses seen in the toxin A-induced mouse enteritis model, rescuing the villus disruption and interleukin-6 production induced by luminal injection of toxin A into the mouse gut. Mechanistically, we found that Peri-4 could reduce toxin A-induced reactive oxygen species production to inhibit the activations of p38MAPK and p21Cip1/Waf1 , which are critical for the cell damages induced by toxin A. These results collectively suggest that the Peri-4 may be a potential therapeutic agent for treating toxin A-induced pseudomembranous colitis. Copyright © 2017 European Peptide Society and John Wiley & Sons, Ltd.


Asunto(s)
Antiinflamatorios/farmacología , Toxinas Bacterianas/antagonistas & inhibidores , Enteritis/tratamiento farmacológico , Enterotoxinas/antagonistas & inhibidores , Proteínas de Insectos/farmacología , Animales , Toxinas Bacterianas/farmacología , Evaluación Preclínica de Medicamentos , Enteritis/inmunología , Enteritis/metabolismo , Enterotoxinas/farmacología , Células HT29 , Humanos , Íleon/efectos de los fármacos , Íleon/inmunología , Íleon/patología , Ratones , Periplaneta/química , Especies Reactivas de Oxígeno/metabolismo , Transducción de Señal
5.
J Cosmet Laser Ther ; 18(8): 448-451, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27593509

RESUMEN

BACKGROUND: Intense focused ultrasound (IFUS) is a novel treatment modality for skin laxity. The delivery of thermal energy to the deeper tissue layers effectively tightens the skin but can also cause significant fat atrophy, limiting its use in patients with a lean face. OBJECTIVES: We sought to evaluate the safety and efficacy of modified IFUS on facial rejuvenation. PATIENTS AND METHODS: This was a retrospective, single-center study of 28 subjects with age-related facial laxity who underwent 3 sessions of IFUS (UltraskinTM, WONTECH Co., Daejeon, Korea) at an interval of four weeks, and then followed up for three months. IFUS was first applied using a 4-MHZ, 4.5-mm transducer followed by a 7-MHZ, 3-mm transducer. Approximately 200-300 treatment lines were applied to the face during each session. Standardized photographs were taken at baseline and follow-ups and were assessed by two independent dermatologists. A questionnaire was used to evaluate patient satisfaction and the incidence of adverse reactions. RESULTS: Twenty-eight subjects with mild-to-moderate age-related facial laxity were included in the study. The mean age of the subjects was 48 (range 29-74) years. About 32.1% of the subjects showed significant improvement and 57.1% showed improvement of facial laxity in their follow-up photographs. All of them (100%) replied that they were either greatly satisfied or satisfied with the results at three-month follow-up. None of the subjects experienced any serious adverse events including fat atrophy after the procedure. CONCLUSION: Modified IFUS (three sessions, four weeks apart, 200-300 treatment lines per session) can be safely performed with good clinical results.


Asunto(s)
Técnicas Cosméticas , Rejuvenecimiento , Envejecimiento de la Piel , Terapia por Ultrasonido/efectos adversos , Terapia por Ultrasonido/métodos , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Satisfacción del Paciente , Estudios Retrospectivos
6.
Biochem Biophys Res Commun ; 448(3): 292-7, 2014 Jun 06.
Artículo en Inglés | MEDLINE | ID: mdl-24796676

RESUMEN

We recently isolated a polypeptide from the earthworm Lumbricus terrestris that is structurally similar to defensin, a well-known antibacterial peptide. An 11-mer antibacterial peptide (NH2-RNRRWCIDQQA), designated Lumbricusin, was synthesized based on the amino acid sequence of the isolated polypeptide. Since we previously reported that CopA3, a dung beetle peptide, enhanced neuronal cell proliferation, we here examined whether Lumbricusin exerted neurotropic and/or neuroprotective effects. Lumbricusin treatment induced a time-dependent increase (∼51%) in the proliferation of human neuroblastoma SH-SY5Y cells. Lumbricusin also significantly inhibited the apoptosis and decreased viability induced by treatment with 6-hydroxy dopamine, a Parkinson's disease-mimicking agent. Immunoblot analyses revealed that Lumbricusin treatment increased ubiquitination of p27(Kip1) protein, a negative regulator of cell-cycle progression, in SH-SY5Y cells, and markedly promoted its degradation. Notably, adenoviral-mediated over-expression of p27(Kip1) significantly blocked the antiapoptotic effect of Lumbricusin in 6-hydroxy dopamine-treated SH-SY5Y cells. These results suggest that promotion of p27(Kip1) degradation may be the main mechanism underlying the neuroprotective and neurotropic effects of Lumbricusin.


Asunto(s)
Péptidos Catiónicos Antimicrobianos/aislamiento & purificación , Proteínas del Helminto/aislamiento & purificación , Fármacos Neuroprotectores/aislamiento & purificación , Oligoquetos/química , Secuencia de Aminoácidos , Animales , Péptidos Catiónicos Antimicrobianos/genética , Péptidos Catiónicos Antimicrobianos/farmacología , Apoptosis/efectos de los fármacos , Línea Celular , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Inhibidor p27 de las Quinasas Dependientes de la Ciclina/genética , Inhibidor p27 de las Quinasas Dependientes de la Ciclina/metabolismo , Proteínas del Helminto/genética , Proteínas del Helminto/farmacología , Humanos , Neurogénesis/efectos de los fármacos , Neuronas/citología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Fármacos Neuroprotectores/química , Fármacos Neuroprotectores/farmacología , Oligoquetos/genética , Oxidopamina/antagonistas & inhibidores , Oxidopamina/toxicidad , Enfermedad de Parkinson/tratamiento farmacológico , Complejo de la Endopetidasa Proteasomal/metabolismo , Proteolisis/efectos de los fármacos
7.
Mar Pollut Bull ; 201: 116248, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38479323

RESUMEN

Recently, there has been a notable rise in social and scientific interest regarding microplastic pollution in coasts where waves significantly influence flow patterns and material transport. This study explores typical short-term movement of buoyant microplastics driven by surf zone processes including wave transformation, breaking, and orbital motion. To track microplastics, Lagrangian Particle Tracking Model (PTM) coupled with Eulerian wave-current interaction model appropriate for coastal hydrodynamics was used. From the simulations, several important findings were observed. (i) In alongshore uniform beaches, lighter and larger buoyant microplastics tended to reach beach more readily. (ii) Accurate predictions of microplastic transport in the surf zone required the consideration of wave breaking. (iii) In alongshore non-uniform coastal bathymetry, rip-currents can send buoyant microplastics offshore, beyond the surf zone.


Asunto(s)
Microplásticos , Contaminantes Químicos del Agua , Plásticos , Contaminantes Químicos del Agua/análisis , Monitoreo del Ambiente , Hidrodinámica
8.
Biochem Biophys Res Commun ; 437(1): 35-40, 2013 Jul 19.
Artículo en Inglés | MEDLINE | ID: mdl-23791873

RESUMEN

We recently demonstrated that the antibacterial peptide, CopA3 (a D-type disulfide dimer peptide, LLCIALRKK), inhibits LPS-induced macrophage activation and also has anticancer activity in leukemia cells. Here, we examined whether CopA3 could affect neuronal cell proliferation. We found that CopA3 time-dependently increased cell proliferation by up to 31 ± 2% in human neuroblastoma SH-SY5Y cells, and up to 29 ± 2% in neural stem cells isolated from neonatal mouse brains. In both cell types, CopA3 also significantly inhibited the apoptosis and viability losses caused by 6-hydroxy dopamine (a Parkinson disease-mimicking agent) and okadaic acid (an Alzheimer's disease-mimicking agent). Immunoblotting revealed that the p27Kip1 protein (a negative regulator of cell cycle progression) was markedly degraded in CopA3-treated SH-SY5Y cells. Conversely, an adenovirus expressing p27Kip1 significantly inhibited the antiapoptotic effects of CopA3 against 6-hydroxy dopamine- and okadaic acid-induced apoptosis, and decreased the neurotropic effects of CopA3. These results collectively suggest that CopA3-mediated protein degradation of p27Kip1 may be the main mechanism through which CopA3 exerts neuroprotective and neurotropic effects.


Asunto(s)
Péptidos Catiónicos Antimicrobianos/farmacología , Apoptosis/efectos de los fármacos , Escarabajos/química , Inhibidor p27 de las Quinasas Dependientes de la Ciclina/metabolismo , Proteínas de Insectos/farmacología , Neuronas/citología , Fármacos Neuroprotectores/farmacología , Péptidos/farmacología , Proteolisis/efectos de los fármacos , Secuencia de Aminoácidos , Animales , Péptidos Catiónicos Antimicrobianos/química , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Semivida , Humanos , Proteínas de Insectos/química , Ratones , Datos de Secuencia Molecular , Células-Madre Neurales/citología , Células-Madre Neurales/efectos de los fármacos , Células-Madre Neurales/metabolismo , Neuroblastoma/patología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Ácido Ocadaico/farmacología , Oxidopamina/farmacología , Péptidos/química
9.
J Pept Sci ; 18(10): 650-6, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22969062

RESUMEN

We recently demonstrated that the insect peptide CopA3 (LLCIALRKK), a disulfide-linked dimeric peptide, exerts antimicrobial and anti-inflammatory activities in a mouse colitis model. Here, we examined whether CopA3 inhibited activation of macrophages by LPS. Exposure of an unseparated mouse peritoneal cell population or isolated peritoneal macrophages to LPS markedly increased secretion of IL-6 and TNF-α; these effects were significantly inhibited by CopA3 treatment. The inhibitory effect of CopA3 was also evident in murine macrophage cell line, RAW 264.7. Western blotting revealed that LPS-induced activation of STAT1 and STAT5 in macrophages was significantly inhibited by CopA3. Inhibition of JAK (STAT1/STAT5 kinase) with AG490 markedly reduced the production of IL-6 and TNF-α in macrophages. Collectively, these observations suggest that CopA3 inhibits macrophage activation by inhibiting activating phosphorylations of the transcription factors, STAT1 and STAT5, and blocking subsequent production of IL-6 and TNF-α and indicate that CopA3 may be useful as an immune-modulating agent.


Asunto(s)
Proteínas de Insectos/farmacología , Insectos/química , Lipopolisacáridos/antagonistas & inhibidores , Activación de Macrófagos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Animales , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Proteínas de Insectos/síntesis química , Proteínas de Insectos/química , Interleucina-6/biosíntesis , Interleucina-6/metabolismo , Lipopolisacáridos/farmacología , Macrófagos/citología , Macrófagos/inmunología , Ratones , Fosforilación , Factor de Transcripción STAT1/metabolismo , Factor de Transcripción STAT5/metabolismo , Factor de Necrosis Tumoral alfa/biosíntesis , Factor de Necrosis Tumoral alfa/metabolismo
10.
Nanotechnology ; 22(24): 245705, 2011 Jun 17.
Artículo en Inglés | MEDLINE | ID: mdl-21508503

RESUMEN

PbTiO(3) (PTO) ferroelectric films on Pt(111) bottom electrode layers covering Ta/glass were prepared using pulsed laser deposition. X-ray diffraction patterns revealed that the PTO films were preferentially (111)-oriented. The films were highly crystalline and had a smooth surface with root mean square (RMS) roughness of 1.5 nm. Ferroelectric properties of the PTO films were characterized using piezoresponse force microscopy (PFM). PFM techniques achieved ferroelectric polarization bits with a minimum width of 22 nm, which corresponds to a potential recording density of 1.3 Tbit/in(2) in ferroelectric storage devices.

11.
Mol Cells ; 44(11): 784-794, 2021 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-34764231

RESUMEN

Leiomyosarcoma (LMS) is a mesenchymal malignancy with a complex karyotype. Despite accumulated evidence, the factors contributing to the development of LMS are unclear. Here, we investigated the role of tight-junction protein 1 (TJP1), a membrane-associated intercellular barrier protein during the development of LMS and the tumor microenvironment. We orthotopically transplanted SK-LMS-1 cells and their derivatives in terms of TJP1 expression by intramuscular injection, such as SK-LMS-1 Sh-Control cells and SK-LMS-1 Sh-TJP1. We observed robust tumor growth in mice transplanted with LMS cell lines expressing TJP1 while no tumor mass was found in mice transplanted with SK-LMS-1 Sh-TJP1 cells with silenced TJP1 expression. Tissues from mice were stained and further analyzed to clarify the effects of TJP1 expression on tumor development and the tumor microenvironment. To identify the TJP1-dependent factors important in the development of LMS, genes with altered expression were selected in SK-LMS-1 cells such as cyclinD1, CSF1 and so on. The top 10% of highly expressed genes in LMS tissues were obtained from public databases. Further analysis revealed two clusters related to cell proliferation and the tumor microenvironment. Furthermore, integrated analyses of the gene expression networks revealed correlations among TJP1, CSF1 and CTLA4 at the mRNA level, suggesting a possible role for TJP1 in the immune environment. Taken together, these results imply that TJP1 contributes to the development of sarcoma by proliferation through modulating cell-cell aggregation and communication through cytokines in the tumor microenvironment and might be a beneficial therapeutic target.


Asunto(s)
Leiomiosarcoma/fisiopatología , Proteína de la Zonula Occludens-1/metabolismo , Animales , Agregación Celular , Línea Celular Tumoral , Proliferación Celular , Progresión de la Enfermedad , Humanos , Ratones , Microambiente Tumoral
12.
Sci Rep ; 8(1): 14183, 2018 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-30242171

RESUMEN

There is a gap between model- or theory-based research outputs, which suggest that the runup and amplification of nonbreaking waves generally increase as the sea bottom slopes decrease, and field observations, which indicate that tsunami damage has been rarely reported in places with vast continental shelfs. To resolve this contradiction, we propose a Lagrangian-like volume tracking paradigm to describe the energy, mass, and momentum of travelling nearshore tsunamis and apply the paradigm to analyse the tsunami damping mechanism at typical geophysical scales. The results support the following conclusions: (i) The suggested paradigm is consistent with field observations; continental shelfs with long and mild slopes can effectively diminish tsunami impacts. (ii) Potential energy becomes significant due to the energy transformation process on steeply sloped bathymetries. (iii) On mild-sloped bathymetries, tsunami potential and kinetic energies are conserved until breaking occurs. After breaking, undular bores attenuate tsunami energies effectively. (iv) For extended continental shelf bathymetries, more of the tsunami mass is reflected offshore.

13.
Radiographics ; 27(3): 791-803, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17495293

RESUMEN

At magnetic resonance (MR) imaging and multidetector computed tomography (CT), artifacts arising from metallic orthopedic hardware are an obstacle to obtaining optimal images. Although various techniques for reducing such artifacts have been developed and corroborated by previous researchers, a new era of more powerful MR imaging and multidetector CT modalities has renewed the importance of a systematic consideration of methods for artifact reduction. Knowledge of the factors that contribute to artifacts, of related theories, and of artifact reduction techniques has become mandatory for radiologists. Factors that affect artifacts on MR images include the composition of the metallic hardware, the orientation of the hardware in relation to the direction of the main magnetic field, the strength of the magnetic field, the pulse sequence type, and other MR imaging parameters (mainly voxel size, which is determined by the field of view, image matrix, section thickness, and echo train length). At multidetector CT, the factors that affect artifacts include the composition of the hardware, orientation of the hardware, acquisition parameters (peak voltage, tube charge, collimation, and acquired section thickness), and reconstruction parameters (reconstructed section thickness, reconstruction algorithm used, and whether an extended CT scale was used). A comparison of images obtained with different hardware and different acquisition and reconstruction parameters facilitates an understanding of methods for reducing or overcoming artifacts related to metallic implants.


Asunto(s)
Artefactos , Aumento de la Imagen/métodos , Interpretación de Imagen Asistida por Computador/métodos , Imagen por Resonancia Magnética/métodos , Metales , Prótesis e Implantes , Tomografía Computarizada por Rayos X/métodos , Humanos , Imagen por Resonancia Magnética/instrumentación , Tomografía Computarizada por Rayos X/instrumentación
14.
Adv Exp Med Biol ; 599: 53-9, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17727247

RESUMEN

The cytotoxic RNase, Onconase (ONC), isolated from amphibian oocytes, was used to study its effect on the radiation response in A549 human NSCLC in vitro and in vivo. In cell culture studies, we found that ONC increased the radiation response by ONC-induced inhibition of O2 consumption (QO2). The occurrence of apoptosis was increased by ONC and was dependent on dosages and time exposure (measured by a Tunnel in situ cell death detection assay). Moreover, ONC inhibited sublethal damage repair (SLDR), confirmed by a split dose experiment. In animal studies, ONC significantly increased the radiation-induced tumor growth delay of A549 tumors in vivo. Using a non-invasive DCE-MRI technology, ONC-induced changes of perfusion were observed in A549 tumors. We concluded that the ONC-induced enhancement in tumor oxygenation was mainly due to the reduction in QO2 rather than an increase in tumor blood flow. This investigation suggests important potential clinical uses of ONC for the treatment of NSCLC cancer patients.


Asunto(s)
Antineoplásicos , Neoplasias Pulmonares , Ribonucleasas/farmacología , Trasplante Heterólogo , Animales , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Línea Celular Tumoral/efectos de los fármacos , Línea Celular Tumoral/efectos de la radiación , Femenino , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/radioterapia , Ratones , Ratones Desnudos , Trasplante de Neoplasias , Ribonucleasas/uso terapéutico
15.
J Microbiol Biotechnol ; 26(4): 693-9, 2016 Apr 28.
Artículo en Inglés | MEDLINE | ID: mdl-26809801

RESUMEN

Clostridium difficile toxin A is known to cause deacetylation of tubulin proteins, which blocks microtubule formation and triggers barrier dysfunction in the gut. Based on our previous finding that the Clostridium difficile toxin A-dependent activation of histone deacetylase 6 (HDAC-6) is responsible for tubulin deacetylation and subsequent microtubule disassembly, we herein examined the possible effect of potassium acetate (PA; whose acetyl group prevents the binding of tubulin to HDAC-6) as a competitive/false substrate. Our results revealed that PA inhibited toxin A-induced deacetylation of tubulin and recovered toxin A-induced microtubule disassembly. In addition, PA treatment significantly decreased the production of IL-6 (a marker of inflamed tissue) in the toxin A-induced mouse enteritis model. An in vitro HDAC assay revealed that PA directly inhibited HDAC-6-mediated tubulin deacetylation, indicating that PA acted as a false substrate for HDAC-6. These results collectively indicate that PA treatment inhibits HDAC-6, thereby reducing the cytotoxicity and inflammatory responses caused by C. difficile toxin A.


Asunto(s)
Toxinas Bacterianas/toxicidad , Enterotoxinas/toxicidad , Inhibidores de Histona Desacetilasas/farmacología , Histona Desacetilasas/metabolismo , Inflamación/prevención & control , Acetato de Potasio/farmacología , Tubulina (Proteína)/metabolismo , Animales , Colitis/tratamiento farmacológico , Colon/citología , Colon/efectos de los fármacos , Modelos Animales de Enfermedad , Enteritis/tratamiento farmacológico , Células HT29 , Histona Desacetilasa 6 , Humanos , Inflamación/tratamiento farmacológico , Interleucina-6/sangre , Masculino , Ratones
16.
J Microbiol Biotechnol ; 26(8): 1446-51, 2016 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-27116994

RESUMEN

Clostridium difficile toxin A causes acute gut inflammation in animals and humans. It is known to downregulate the tight junctions between colonic epithelial cells, allowing luminal contents to access body tissues and trigger acute immune responses. However, it is not yet known whether this loss of the barrier function is a critical factor in the progression of toxin A-induced pseudomembranous colitis. We previously showed that NADH:quinone oxidoreductase 1 (NQO1) KO (knockout) mice spontaneously display weak gut inflammation and a marked loss of colonic epithelial tight junctions. Moreover, NQO1 KO mice exhibited highly increased inflammatory responses compared with NQO1 WT (wild-type) control mice when subjected to DSS-induced experimental colitis. Here, we tested whether toxin A could also trigger more severe inflammatory responses in NQO1 KO mice compared with NQO1 WT mice. Indeed, our results show that C. difficile toxin A-mediated enteritis is significantly enhanced in NQO1 KO mice compared with NQO1 WT mice. The levels of fluid secretion, villus disruption, and epithelial cell apoptosis were also higher in toxin A-treated NQO1 KO mice compared with WT mice. The previous and present results collectively show that NQO1 is involved in the formation of tight junctions in the small intestine, and that defects in NQO1 enhance C. difficile toxin A-induced acute inflammatory responses, presumably via the loss of epithelial cell tight junctions.


Asunto(s)
Toxinas Bacterianas/toxicidad , Enteritis/microbiología , Enteritis/fisiopatología , Enterotoxinas/toxicidad , NAD(P)H Deshidrogenasa (Quinona)/genética , NAD(P)H Deshidrogenasa (Quinona)/fisiología , Animales , Apoptosis , Toxinas Bacterianas/administración & dosificación , Clostridioides difficile/fisiología , Enteritis/patología , Enterotoxinas/administración & dosificación , Células Epiteliales/patología , Humanos , Mucosa Intestinal/patología , Ratones , Ratones Noqueados , NAD(P)H Deshidrogenasa (Quinona)/deficiencia , Uniones Estrechas/patología
17.
J Microbiol Biotechnol ; 25(10): 1640-7, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26215270

RESUMEN

We recently reported that the antimicrobial peptide Lumbricusin (NH2-RNRRWCIDQQA), isolated from the earthworm, increases cell proliferation in neuroblastoma SH-SY5Y cells. Here, we investigated whether Lumbricusin has neurotropic activity in mouse neural stem cells (MNSCs) and a protective effect in a mouse model of Parkinson's disease (PD). In MNSCs isolated from mouse brains, Lumbricusin treatment significantly increased cell proliferation (up to 12%) and reduced the protein expression of p27(Kip1) through proteasomal protein degradation but not transcriptional regulation. Lumbricusin inhibited the 6-OHDA-induced apoptosis of MNSCs, and also showed neuroprotective effects in a mouse PD model, ameliorating the motor impairments seen in the pole, elevated body swing, and rotation tests. These results suggest that the Lumbricusin-induced promotion of neural cell proliferation via p27(Kip1) degradation has a protective effect in an experimental PD model. Thus, the antimicrobial peptide Lumbricusin could possibly be developed as a potential therapeutic agent for the treatment of PD.


Asunto(s)
Péptidos Catiónicos Antimicrobianos/metabolismo , Neuronas Dopaminérgicas/efectos de los fármacos , Proteínas del Helminto/metabolismo , Trastornos Motores/tratamiento farmacológico , Fármacos Neuroprotectores/metabolismo , Enfermedad de Parkinson/tratamiento farmacológico , Enfermedad de Parkinson/patología , Animales , Péptidos Catiónicos Antimicrobianos/administración & dosificación , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Modelos Animales de Enfermedad , Proteínas del Helminto/administración & dosificación , Ratones , Células-Madre Neurales/efectos de los fármacos , Células-Madre Neurales/fisiología , Fármacos Neuroprotectores/administración & dosificación , Resultado del Tratamiento
18.
Magn Reson Imaging ; 22(3): 307-14, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15062926

RESUMEN

This study compared two methods, corrected (separation of T(1) and T(2)* effects) and uncorrected, in order to determine the suitability of the perfusion and permeability measures through Delta R(2)* and Delta R(1) analyses. A dynamic susceptibility contrast dual gradient echo (DSC-DGE) was used to image the fixed phantoms and flow phantoms (Sephadex perfusion phantoms and dialyzer phantom for the permeability measurements). The results confirmed that the corrected relaxation rate was linearly proportional to gadolinium-diethyltriamine pentaacetic acid (Gd-DTPA) concentration, whereas the uncorrected relaxation rate did not in the fixed phantom and simulation experiments. For the perfusion measurements, it was found that the correction process was necessary not only for the Delta R(1) time curve but also for the Delta R(2)* time curve analyses. Perfusion could not be measured without correcting the Delta R(2)* time curve. The water volume, which was expressed as the perfusion amount, was found to be closer to the theoretical value when using the corrected Delta R(1) curve in the calculations. However, this may occur in the low concentration of Gd-DTPA in tissue used in this study. For the permeability measurements based on the two-compartment model, the permeability factor (k(ev); e = extravascular, v = vascular) from the outside to the inside of the hollow fibers was greater in the corrected Delta R(1) method than in the uncorrected Delta R(1) method. The differences between the corrected and the uncorrected Delta R(1) values were confirmed by the simulation experiments. In conclusion, this study proposes that the correction for the relaxation rates, Delta R(2)* and Delta R(1), is indispensable in making accurate perfusion and permeability measurements, and that DSC-DGE is a useful method for obtaining information on perfusion and permeability, simultaneously.


Asunto(s)
Medios de Contraste/química , Gadolinio DTPA/química , Imagen por Resonancia Magnética/métodos , Perfusión , Permeabilidad , Fantasmas de Imagen , Algoritmos , Vasos Sanguíneos/metabolismo , Volumen Sanguíneo , Medios de Contraste/farmacocinética , Extravasación de Materiales Terapéuticos y Diagnósticos , Gadolinio DTPA/farmacocinética , Aumento de la Imagen , Imagen por Resonancia Magnética/instrumentación , Modelos Biológicos
19.
Anal Sci ; 19(7): 1051-4, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12880091

RESUMEN

An etching technique for the determination of the metallic impurities distribution in silicon wafers has been developed. An area of 10 mmphi and 10 microm depth was etched by 100 microL of an etching solution with a HF and HNO3 mixture. The acid matrix was evaporated on the wafer surface by IR lamp illumination and vacuum exhaust. Metallic impurities remaining on the wafer surface were redissolved into the collection solution, which was measured by electrothermal atomic absorption spectrometry (ET-AAS). The recovery invested by local etching/ET-AAS was within 95 - 112% for Fe, Cu and Ni. The detection limit (3sigma) for Fe, Cu and Ni in silicon was 1 x 10(13) atoms/cm3. To confirm the applicability, local etching was applied to evaluate the effects of metallic impurities in a gettering study and the electronic properties of semiconductor devices. It was found that local etching is a useful sample preparation technique for the analysis of metallic impurities in a specific area on a silicon wafer.

20.
J Microbiol Biotechnol ; 24(5): 696-703, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24509250

RESUMEN

Clostridium difficile causes mucosal damage and diarrhea by releasing two exotoxins: toxin A and toxin B. C. difficile colitis is associated with alterations in bowel flora and the failure to mount an effective antibody response. The aim of the current study was to investigate whether antitoxin sera prevent toxin-A-induced apoptosis, cytoskeletal disaggregation, cell detachment, and tight junction loss in cultured colonic epithelial cells. Serum samples were isolated from mice that survived a C. difficile infection following antibiotic treatment, and the antitoxin effects of these samples were investigated in toxin-A-exposed HT29 colonic epithelial cells and a toxin-A-induced animal model of gut inflammation. Unchallenged mice did not produce IgG against toxin A, whereas serum (antiserum) from C. difficile-challenged mice showed significant IgG responses against toxin A. Treatment with the antiserum markedly inhibited mucosal damage and inflammation in the toxin-A-treated mouse model. In contrast to control mouse serum, the antiserum also markedly inhibited toxin-A-induced DNA fragmentation, dephosphorylation of paxillin and Epo receptor (EpoR), deacetylation of tubulin, and upregulation of p21(WAF1/CIP1) and p53. Taken together, these results reveal that the generated antitoxin serum has biotherapeutic effects in preventing various C. difficile toxin-A-induced cellular toxicities.


Asunto(s)
Toxinas Bacterianas/efectos adversos , Clostridioides difficile/inmunología , Enterocolitis Seudomembranosa/inmunología , Enterotoxinas/efectos adversos , Sueros Inmunes/inmunología , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/metabolismo , Animales , Antitoxinas/inmunología , Apoptosis/efectos de los fármacos , Apoptosis/inmunología , Muerte Celular/efectos de los fármacos , Muerte Celular/inmunología , Línea Celular , Colitis/inducido químicamente , Colitis/inmunología , Colitis/metabolismo , Modelos Animales de Enfermedad , Células HT29 , Humanos , Sueros Inmunes/farmacología , Mucosa Intestinal/inmunología , Mucosa Intestinal/microbiología , Mucosa Intestinal/patología , Masculino , Ratones , Transducción de Señal , Estrés Fisiológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA